An apparatus and method for non-invasive treatment in lieu of cosmetic surgery is disclosed. The apparatus comprises a combination of a high and low voltage pulse generators connected to two or more electrodes placed on a treatment site of the patient's body. high voltage pulses, delivered to the electrodes, create an electric field that kills subcutaneous fat cells. low voltage pulses, delivered to the same or individual electrodes provide transcutaneous electrical nerve stimulation (tens), blocking the signals of discomfort or pain that may arise from the high voltage pulsing.
|
17. A method for reducing subcutaneous fat deposits in a treatment volume by electroporation with improved patient comfort, said method comprising:
applying a plurality of electroporation electric field pulses to the treatment volume to induce subcutaneous fat cell death by electroporation; and
applying a plurality of tens electric field pulses at least to the treatment volume to improve patient comfort by transcutaneous electric nerve stimulation at least in the treatment volume.
1. An apparatus for reducing subcutaneous fat deposits by electroporation with improved comfort of patients comprising:
an applicator comprising two sets of electrodes, the first and the second, said first set of electrodes are high voltage electrodes adapted for engaging the skin of a patient and applying a high amplitude pulsed electric field to the area of skin and the subcutaneous volume of tissues to be treated by electroporation, said second set of electrodes adapted for transcutaneous electrical nerve stimulation of the skin and the volume of the subcutaneous tissue over an area generally larger than the area of electroporation treatment;
a generator of high voltage pulses for applying pulsed electric field to the first set of electrodes, said pulses generating an electric field above the upper electroporation limit for subcutaneous fat cells in the volume of the subcutaneous tissue to be treated;
a generator for generating low voltage pulses for applying pulsed electric field to the second set of electrodes, said amplitude of the electric field is adapted for Transcutaneous Electrical Nerve Stimulation (tens) of the skin and subcutaneous tissue;
a synchronizing circuit connected to said high and said low voltage pulse generators and providing triggering of the high voltage pulses with a controllable delay after the tens pulses, and
connectors connecting said generators of high and low voltage electrical pulses with corresponding high and low voltage electrodes.
12. An apparatus for reducing subcutaneous fat deposits in a predetermined treatment volume beneath a predetermined area of a patient's skin by electroporation with improved comfort for the patient, said apparatus comprises:
first and second electrode sets, wherein said first electrode set comprises:
at least a pair of electroporation electrodes, said electroporation electrodes being provided for applying a pulsed electric field to the predetermined area of skin and the subcutaneous volume of tissues; and
wherein said second electrode set comprises:
at least a pair of tens electrodes, said tens electrodes being configured for transcutaneous electrical stimulation of the patient over a tissue volume including at least the predetermined treatment volume;
a generator of high voltage pulses for applying a pulsed electric field to the predetermined area via said first electrode set, said pulses generating an electric field above the upper electroporation limit for subcutaneous fat cells in the volume of the subcutaneous tissue to be treated;
a generator for generating low voltage pulses for applying a pulsed electric field to the predetermined area via said second electrode set, wherein the amplitude of the low voltage electric field is chosen to provide transcutaneous electrical nerve stimulation (tens) of the nerves of the skin and subcutaneous tissue in an area larger than the predetermined area;
a synchronizing circuit connected to said high and said low voltage pulse generators and providing triggering of the high voltage pulses with a controllable delay after the tens pulses, and
connectors connecting said generators of high and low voltage electrical pulses with corresponding electroporation and tens electrodes.
11. A method for reducing subcutaneous fat deposits by electroporation with improved comfort of patients comprising:
providing an applicator comprising first and second sets of electrodes, wherein first set of electrodes are high voltage electrodes are configured for engaging the skin of a patient and applying a high amplitude pulsed electric field to the area of skin and the subcutaneous volume of tissues to be treated by electroporation and wherein said second set of electrodes are configured for transcutaneous electrical nerve stimulation of the skin and the volume of the subcutaneous tissue over an area generally larger than the area of electroporation treatment;
providing a generator of high voltage pulses for applying pulsed electric field to the first set of electrodes, said pulses generating an electric field above the upper electroporation limit for subcutaneous fat cells in the volume of the subcutaneous tissue to be treated;
providing a generator for generating low voltage pulses for applying pulsed electric field to the second set of electrodes, said amplitude of the electric field providing transcutaneous electrical nerve stimulation (tens) of the skin and subcutaneous tissue;
providing a synchronizing circuit connected to said high and said low voltage pulse generators and providing triggering of the high voltage pulses with a controllable delay after the tens pulses;
connecting said generators of high and low voltage electrical pulses with corresponding high and low voltage electrodes; and
applying tens pulses via said second set of electrodes to the area in and around of the area to be treated and high voltage pulses via said first set of electrodes with an amplitude sufficient to cause death to subcutaneous fat cells.
2. An apparatus according to
3. An apparatus according to
4. An apparatus according to
5. An apparatus according to
6. An apparatus according to
8. An apparatus according to
9. An apparatus according to
10. An apparatus according to
13. An apparatus according to
14. An apparatus according to
15. An apparatus according to
18. The method of
19. The method of
20. The method of
21. The method of
|
For sensory nerves in the human skin, τ∇0.5 ms (millisecond) and b∇2 (mA/cm2). The strength-duration curves illustrating the Blair equation for different excitable tissues are shown in
An excitation threshold of a nerve depends not only upon the duration of the stimulating pulse but also upon the immediate local excitation history of the nerve.
As can be seen from the
The threshold of excitation of a cell at rest depends not only on the duration of the electrical stimulus but also on the waveform of the stimulus. The threshold for a bipolar pulse, consisting of two parts, a positive one and identical in shape but negative in polarity, is higher than that for a unipolar pulse. The reason for that is that the cell launches an acting potential only when the resting threshold of the excitation is reached. This happens when a change of the electrical charges on both sides of the membrane occurs that depolarizes it from −90 mV to −60 mV. If a bipolar pulse is applied to the cell, only the first half of the pulse causes a depolarization of the cellular membrane that can lead to a firing of an action potential. If the cell is not ready to fire after the first half of the pulse, when the current reverses and begins to flow the other direction in the second half of the pulse, the reversing electric current polarizes the membrane back to the previous level of −90 mV. In other words, all nerves including sensory are less sensitive to bipolar pulses than to unipolar of the same overall duration. Actually, their sensitivity approximately corresponds to that of a unipolar pulse with a half duration.
Bipolar rectangular pulses are known to be very efficient in cell killing by electroporation. Contrary to the sensitivity of excitable cells to electric stimulus, both directions of the electrical field, that is, positive (+) and negative (−), are equally efficient in creating pores in cellular membranes. This efficiency results because electroporation is a process is related to the difference in the energy of the porous and non-porous membrane in the presence of an electric field. This energy difference depends on the square of the amplitude (or strength) of the electric field (i.e., E2) and does not depend on the sign or polarity (+ or −) of the electric field.
From a practical stand point, however, applying balanced pulses during in-vivo electroporation treatment has one important advantage. Contrary to unipolar pulsing, that carries a direct current component into the treated tissue and creates undesired electrolytic effects on the interface of the electrodes and tissues, bipolar pulsing is free from these drawbacks. With the bipolar pulsing problems such as metal depositions from the electrodes or chemical decomposition of tissue during treatment are largely if not completely avoided.
These advantageous properties of balanced pulses, namely, lower excitability of the nerve cells, high efficiency in cell killing and freedom from electrolytic effects, make using rectangular bipolar balanced pulses a preferred mode for electroporation pulsing in the current invention. Technically, balancing of two pulses of the opposite polarities may be easily achieved by using a pulse generator having a direct current blocking capacitor electrically coupled in series to the transcutaneous electrodes.
The time diagram of the pulses applied to the electrodes are shown in
The EP pulses depend upon the size of the electrodes and the distance between them and may be in the range of about 50 V to about 5000 V with a duration of about 10 microseconds to about 1.0 milliseconds. The TENS pulses may have duration of about 20 to about 1000 microseconds.
In
In operation, apparatus in accord with the present invention will include using TENS electrodes to create an anesthetic effect in at least the treatment volume and preferentially in a larger volume of patient tissue that includes the treatment volume. This anesthetic effect can be created by application of TENS pulses to the patient. Preferably subsequently to the creation of the anesthetic effect, EP pulses can be applied to the treatment, resulting in the death of some or all of the subcutaneous fat cells in the treatment volume. Other patient tissue treatment volumes can then be treated similarly. In this manner then, the present invention provides apparatus and method for reducing subcutaneous fat deposits by electroporation with improved comfort of patients.
The present invention has been described in language more or less specific as to the apparatus and method features. It is to be understood, however, that the present invention is not limited to the specific features described, since the apparatus and method herein disclosed comprise exemplary forms of putting the present invention into effect. The invention is, therefore, claimed in any of its forms or modifications within the proper scope of the appended claims appropriately interpreted in accordance with the doctrine of equivalency and other applicable judicial doctrines.
Jaafar, Ali, Chornenky, Victor
Patent | Priority | Assignee | Title |
10092346, | Jul 20 2010 | Zeltiq Aesthetics, Inc. | Combined modality treatment systems, methods and apparatus for body contouring applications |
10117707, | Apr 29 2008 | Virginia Tech Intellectual Properties, Inc | System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies |
10154874, | Apr 29 2008 | Virginia Tech Intellectual Properties, Inc | Immunotherapeutic methods using irreversible electroporation |
10201380, | Jan 31 2014 | ZELTIQ AESTHETICS, INC | Treatment systems, methods, and apparatuses for improving the appearance of skin and providing other treatments |
10238447, | Apr 29 2008 | Virginia Tech Intellectual Properties, Inc | System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress |
10245098, | Apr 29 2008 | Virginia Tech Intellectual Properties, Inc | Acute blood-brain barrier disruption using electrical energy based therapy |
10245105, | Apr 29 2008 | Virginia Tech Intellectual Properties, Inc. | Electroporation with cooling to treat tissue |
10272178, | Apr 29 2008 | Virginia Tech Intellectual Properties, Inc | Methods for blood-brain barrier disruption using electrical energy |
10286108, | Apr 29 2008 | Virginia Tech Intellectual Properties, Inc. | Irreversible electroporation to create tissue scaffolds |
10292755, | Apr 09 2009 | Virginia Tech Intellectual Properties, Inc. | High frequency electroporation for cancer therapy |
10292859, | Sep 26 2006 | Zeltiq Aesthetics, Inc. | Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile |
10383787, | May 18 2007 | Zeltiq Aesthetics, Inc. | Treatment apparatus for removing heat from subcutaneous lipid-rich cells and massaging tissue |
10448989, | Apr 09 2009 | Virginia Tech Intellectual Properties, Inc | High-frequency electroporation for cancer therapy |
10470822, | Apr 29 2008 | Virginia Tech Intellectual Properties, Inc | System and method for estimating a treatment volume for administering electrical-energy based therapies |
10471254, | May 12 2014 | Virginia Tech Intellectual Properties, Inc | Selective modulation of intracellular effects of cells using pulsed electric fields |
10524956, | Jan 07 2016 | ZELTIQ AESTHETICS, INC | Temperature-dependent adhesion between applicator and skin during cooling of tissue |
10537379, | Apr 29 2008 | Virginia Tech Intellectual Properties, Inc. | Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds |
10555831, | May 10 2016 | ZELTIQ AESTHETICS, INC | Hydrogel substances and methods of cryotherapy |
10568759, | Aug 19 2014 | ZELTIQ AESTHETICS, INC | Treatment systems, small volume applicators, and methods for treating submental tissue |
10575890, | Jan 31 2014 | ZELTIQ AESTHETICS, INC | Treatment systems and methods for affecting glands and other targeted structures |
10675176, | Mar 19 2014 | ZELTIQ AESTHETICS, INC | Treatment systems, devices, and methods for cooling targeted tissue |
10675178, | Aug 21 2007 | ZELTIQ AESTHETICS, INC | Monitoring the cooling of subcutaneous lipid-rich cells, such as the cooling of adipose tissue |
10682297, | May 10 2016 | ZELTIQ AESTHETICS, INC | Liposomes, emulsions, and methods for cryotherapy |
10694972, | Dec 15 2014 | Virginia Polytechnic Institute and State University; Virginia Tech Intellectual Properties, Inc | Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment |
10702326, | Jul 15 2011 | Virginia Tech Intellectual Properties, Inc | Device and method for electroporation based treatment of stenosis of a tubular body part |
10702337, | Jun 27 2016 | GALVANIZE THERAPEUTICS, INC | Methods, apparatuses, and systems for the treatment of pulmonary disorders |
10765552, | Feb 18 2016 | ZELTIQ AESTHETICS, INC | Cooling cup applicators with contoured heads and liner assemblies |
10806500, | Jan 31 2014 | Zeltiq Aesthetics, Inc. | Treatment systems, methods, and apparatuses for improving the appearance of skin and providing other treatments |
10828085, | Apr 29 2008 | Virginia Tech Intellectual Properties, Inc | Immunotherapeutic methods using irreversible electroporation |
10828086, | Apr 29 2008 | Virginia Tech Intellectual Properties, Inc | Immunotherapeutic methods using irreversible electroporation |
10912599, | Jan 31 2014 | Zeltiq Aesthetics, Inc. | Compositions, treatment systems and methods for improved cooling of lipid-rich tissue |
10935174, | Aug 19 2014 | ZELTIQ AESTHETICS, INC | Stress relief couplings for cryotherapy apparatuses |
10939958, | Jun 27 2016 | GALVANIZE THERAPEUTICS, INC | Methods, apparatuses, and systems for the treatment of pulmonary disorders |
10952891, | May 13 2014 | ZELTIQ AESTHETICS, INC | Treatment systems with adjustable gap applicators and methods for cooling tissue |
10959772, | Apr 29 2008 | Virginia Tech Intellectual Properties, Inc. | Blood-brain barrier disruption using electrical energy |
11076879, | Apr 26 2017 | ZELTIQ AESTHETICS, INC | Shallow surface cryotherapy applicators and related technology |
11154418, | Oct 19 2015 | ZELTIQ AESTHETICS, INC | Vascular treatment systems, cooling devices, and methods for cooling vascular structures |
11179269, | Sep 26 2006 | Zeltiq Aesthetics, Inc. | Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile |
11219549, | Sep 26 2006 | Zeltiq Aesthetics, Inc. | Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile |
11224536, | Apr 30 2009 | Zeltiq Aesthetics, Inc. | Device, system and method of removing heat from subcutaneous lipid-rich cells |
11254926, | Apr 29 2008 | Virginia Tech Intellectual Properties, Inc. | Devices and methods for high frequency electroporation |
11272979, | Apr 29 2008 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies |
11291606, | May 18 2007 | Zeltiq Aesthetics, Inc. | Treatment apparatus for removing heat from subcutaneous lipid-rich cells and massaging tissue |
11311329, | Mar 13 2018 | Virginia Polytechnic Institute and State University; Virginia Tech Intellectual Properties, Inc; VIRGINA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY | Treatment planning for immunotherapy based treatments using non-thermal ablation techniques |
11369433, | Jun 27 2016 | GALVANIZE THERAPEUTICS, INC | Methods, apparatuses, and systems for the treatment of pulmonary disorders |
11382681, | Apr 09 2009 | Virginia Tech Intellectual Properties, Inc. | Device and methods for delivery of high frequency electrical pulses for non-thermal ablation |
11382790, | May 10 2016 | ZELTIQ AESTHETICS, INC | Skin freezing systems for treating acne and skin conditions |
11395760, | Nov 09 2006 | Zeltiq Aesthetics, Inc. | Tissue treatment methods |
11406820, | May 12 2014 | Virginia Tech Intellectual Properties, Inc | Selective modulation of intracellular effects of cells using pulsed electric fields |
11446175, | Jul 31 2018 | ZELTIQ AESTHETICS, INC | Methods, devices, and systems for improving skin characteristics |
11452634, | Apr 30 2009 | Zeltiq Aesthetics, Inc. | Device, system and method of removing heat from subcutaneous lipid-rich cells |
11453873, | Apr 29 2008 | Virginia Tech Intellectual Properties, Inc. | Methods for delivery of biphasic electrical pulses for non-thermal ablation |
11583438, | Aug 21 2007 | ZELTIQ AESTHETICS, INC | Monitoring the cooling of subcutaneous lipid-rich cells, such as the cooling of adipose tissue |
11607271, | Apr 29 2008 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating a treatment volume for administering electrical-energy based therapies |
11607537, | Dec 05 2017 | Virginia Tech Intellectual Properties, Inc | Method for treating neurological disorders, including tumors, with electroporation |
11638603, | Apr 09 2009 | Virginia Tech Intellectual Properties, Inc | Selective modulation of intracellular effects of cells using pulsed electric fields |
11655466, | Apr 29 2008 | Virginia Tech Intellectual Properties, Inc. | Methods of reducing adverse effects of non-thermal ablation |
11707629, | May 28 2009 | AngioDynamics, Inc. | System and method for synchronizing energy delivery to the cardiac rhythm |
11723710, | Nov 17 2016 | AngioDynamics, Inc. | Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode |
11737810, | Apr 29 2008 | Virginia Tech Intellectual Properties, Inc | Immunotherapeutic methods using electroporation |
11779395, | Sep 28 2011 | AngioDynamics, Inc. | Multiple treatment zone ablation probe |
11819257, | Jan 31 2014 | Zeltiq Aesthetics, Inc. | Compositions, treatment systems and methods for improved cooling of lipid-rich tissue |
11890046, | Apr 29 2008 | Virginia Tech Intellectual Properties, Inc | System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress |
11903690, | Dec 15 2014 | Virginia Tech Intellectual Properties, Inc. | Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment |
11925405, | Mar 13 2018 | Virginia Tech Intellectual Properties, Inc | Treatment planning system for immunotherapy enhancement via non-thermal ablation |
11931096, | Oct 13 2010 | AngioDynamics, Inc. | System and method for electrically ablating tissue of a patient |
11950835, | Jun 28 2019 | AngioDynamics, Inc | Cycled pulsing to mitigate thermal damage for multi-electrode irreversible electroporation therapy |
11952568, | Apr 29 2008 | Virginia Tech Intellectual Properties, Inc. | Device and methods for delivery of biphasic electrical pulses for non-thermal ablation |
11957405, | Jun 13 2013 | AngioDynamics, Inc. | Methods of sterilization and treating infection using irreversible electroporation |
11974800, | Apr 29 2008 | Virginia Tech Intellectual Properties, Inc. | Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds |
11986421, | Sep 26 2006 | ZELTIQ AESTHETICS, INC | Cooling devices with flexible sensors |
12059197, | Apr 29 2008 | Virginia Tech Intellectual Properties, Inc. | Blood-brain barrier disruption using reversible or irreversible electroporation |
12070411, | Apr 28 2006 | Zeltiq Aesthetics, Inc. | Cryoprotectant for use with a treatment device for improved cooling of subcutaneous lipid-rich cells |
12102376, | Feb 08 2012 | AngioDynamics, Inc. | System and method for increasing a target zone for electrical ablation |
12102557, | Jul 31 2018 | Zeltiq Aesthetics, Inc. | Methods, devices, and systems for improving skin characteristics |
12114911, | Aug 28 2014 | AngioDynamics, Inc. | System and method for ablating a tissue site by electroporation with real-time pulse monitoring |
8676338, | Jul 20 2010 | ZELTIQ AESTHETICS, INC | Combined modality treatment systems, methods and apparatus for body contouring applications |
8702774, | Apr 30 2009 | Zeltiq Aesthetics, Inc.; ZELTIQ AESTHETICS, INC | Device, system and method of removing heat from subcutaneous lipid-rich cells |
9314368, | Jan 25 2010 | ZELTIQ AESTHETICS, INC | Home-use applicators for non-invasively removing heat from subcutaneous lipid-rich cells via phase change coolants, and associates devices, systems and methods |
9375345, | Sep 26 2006 | Zeltiq Aesthetics, Inc. | Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile |
9408745, | Aug 21 2007 | ZELTIQ AESTHETICS, INC | Monitoring the cooling of subcutaneous lipid-rich cells, such as the cooling of adipose tissue |
9457183, | Jun 15 2011 | Tripep AB | Injection needle and device |
9545523, | Mar 14 2013 | ZELTIQ AESTHETICS, INC | Multi-modality treatment systems, methods and apparatus for altering subcutaneous lipid-rich tissue |
9598691, | Apr 29 2008 | Virginia Tech Intellectual Properties, Inc | Irreversible electroporation to create tissue scaffolds |
9655770, | Jul 13 2007 | Zeltiq Aesthetics, Inc. | System for treating lipid-rich regions |
9737434, | Dec 17 2008 | Zeltiq Aestehtics, Inc. | Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells |
9757196, | Sep 28 2012 | AngioDynamics, Inc. | Multiple treatment zone ablation probe |
9844460, | Mar 14 2013 | ZELTIQ AESTHETICS, INC | Treatment systems with fluid mixing systems and fluid-cooled applicators and methods of using the same |
9844461, | Jan 25 2010 | ZELTIQ AESTHETICS, INC | Home-use applicators for non-invasively removing heat from subcutaneous lipid-rich cells via phase change coolants |
9861421, | Jan 31 2014 | ZELTIQ AESTHETICS, INC | Compositions, treatment systems and methods for improved cooling of lipid-rich tissue |
9861520, | Apr 30 2009 | Zeltiq Aesthetics, Inc. | Device, system and method of removing heat from subcutaneous lipid-rich cells |
9867652, | Apr 29 2008 | Virginia Tech Intellectual Properties, Inc | Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds |
9888956, | Jan 22 2013 | AngioDynamics, Inc | Integrated pump and generator device and method of use |
9895189, | Jun 13 2013 | AngioDynamics, Inc. | Methods of sterilization and treating infection using irreversible electroporation |
D777338, | Mar 20 2014 | ZELTIQ AESTHETICS, INC | Cryotherapy applicator for cooling tissue |
Patent | Priority | Assignee | Title |
1653819, | |||
4016886, | Nov 26 1974 | The United States of America as represented by the United States Energy | Method for localizing heating in tumor tissue |
4226246, | May 27 1977 | Carba Societe Anonyme | Apparatus for maintaining the negative potential of human, animal, and plant cells |
4262672, | Jan 02 1978 | Acupuncture instrument | |
4407943, | Dec 16 1976 | MILLIPORE INVESTMENT HOLDINGS LIMITED, A CORP OF DE | Immobilized antibody or antigen for immunoassay |
4810963, | Apr 03 1984 | Public Health Laboratory Service Board | Method for investigating the condition of a bacterial suspension through frequency profile of electrical admittance |
4907601, | Jun 15 1988 | Etama AG | Electrotherapy arrangement |
4946793, | May 08 1987 | Electropore, Inc.; ELECTROPORE, INC , A DE CORP | Impedance matching for instrumentation which electrically alters vesicle membranes |
5019034, | Jan 21 1988 | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, THE, A CORP OF MA | Control of transport of molecules across tissue using electroporation |
5052391, | Oct 22 1990 | R F P , INC | High frequency high intensity transcutaneous electrical nerve stimulator and method of treatment |
5058605, | Feb 22 1989 | Ceske vysoke uceni technicke | Method and device for the controlled local, non-invasive application of DC pulses to human and animal tissues |
5098843, | Jun 04 1987 | Apparatus for the high efficiency transformation of living cells | |
5134070, | Jun 04 1990 | ALLAN PIASETZKI, GREGORY | Method and device for cell cultivation on electrodes |
5173158, | Jul 22 1991 | Apparatus and methods for electroporation and electrofusion | |
5193537, | Jun 12 1990 | ZOLL Medical Corporation | Method and apparatus for transcutaneous electrical cardiac pacing |
5273525, | Aug 13 1992 | GENETRONICS, INC | Injection and electroporation apparatus for drug and gene delivery |
5283194, | Jul 22 1991 | Apparatus and methods for electroporation and electrofusion | |
5318563, | Jun 04 1992 | RUTH MALIS, REPRESENTATIVE , ESTATE OF LEONARD I MALIS, DECEASED | Bipolar RF generator |
5328451, | Aug 15 1991 | Board of Regents, The University of Texas System | Iontophoretic device and method for killing bacteria and other microbes |
5389069, | Jan 21 1988 | Massachusetts Institute of Technology | Method and apparatus for in vivo electroporation of remote cells and tissue |
5403311, | Mar 29 1993 | Boston Scientific Scimed, Inc | Electro-coagulation and ablation and other electrotherapeutic treatments of body tissue |
5425752, | Nov 25 1991 | Method of direct electrical myostimulation using acupuncture needles | |
5439440, | Apr 01 1993 | OncoSec Medical Incorporated | Electroporation system with voltage control feedback for clinical applications |
5458625, | May 04 1994 | Transcutaneous nerve stimulation device and method for using same | |
5533999, | Aug 23 1993 | REFRACTEC INC | Method and apparatus for modifications of visual acuity by thermal means |
5536240, | Aug 12 1992 | VENTURE LENDING & LEASING, INC | Medical probe device and method |
5575811, | Jul 08 1993 | PROJECT TROJAN INTELLECTUAL PROPERTY ACQUISITION, LLC; AUSLO RESEARCH LLC | Benign prostatic hyperplasia treatment catheter with urethral cooling |
5626146, | Dec 18 1992 | British Technology Group Limited | Electrical impedance tomography |
5634899, | Aug 20 1993 | VENTION MEDICAL ADVANCED COMPONENTS, INC | Simultaneous cardiac pacing and local drug delivery method |
5674267, | Mar 30 1993 | Centre National de la Recherche Scientifique | Electric pulse applicator using pairs of needle electrodes for the treatment of biological tissue |
5702359, | Apr 01 1993 | OncoSec Medical Incorporated | Needle electrodes for mediated delivery of drugs and genes |
5720921, | Mar 10 1995 | MaxCyte, Inc | Flow electroporation chamber and method |
5778894, | Apr 18 1996 | FD MANAGEMENT, INC | Method for reducing human body cellulite by treatment with pulsed electromagnetic energy |
5782882, | Nov 30 1995 | Koninklijke Philips Electronics N V | System and method for administering transcutaneous cardiac pacing with transcutaneous electrical nerve stimulation |
5800378, | Aug 12 1992 | Vidamed, Inc. | Medical probe device and method |
5810762, | Apr 10 1995 | OncoSec Medical Incorporated | Electroporation system with voltage control feedback for clinical applications |
5836905, | Jun 20 1994 | Apparatus and methods for gene therapy | |
5843026, | Aug 12 1992 | Vidamed, Inc. | BPH ablation method and apparatus |
5873849, | Apr 24 1997 | Ichor Medical Systems, Inc. | Electrodes and electrode arrays for generating electroporation inducing electrical fields |
5919142, | Jun 22 1995 | BTG International Limited | Electrical impedance tomography method and apparatus |
5947889, | Jan 17 1995 | Balloon catheter used to prevent re-stenosis after angioplasty and process for producing a balloon catheter | |
5983131, | Aug 11 1995 | Massachusetts Institute of Technology | Apparatus and method for electroporation of tissue |
5991697, | Dec 31 1996 | CALIFORNIA, UNIVERSITY OF, REGENTS OF THE, THE | Method and apparatus for optical Doppler tomographic imaging of fluid flow velocity in highly scattering media |
5999847, | Oct 21 1997 | Apparatus and method for delivery of surgical and therapeutic agents | |
6009347, | Jan 27 1998 | OncoSec Medical Incorporated | Electroporation apparatus with connective electrode template |
6010613, | Dec 08 1995 | CELLECTIS S A | Method of treating materials with pulsed electrical fields |
6016452, | Mar 19 1996 | Dynamic heating method and radio frequency thermal treatment | |
6041252, | Jun 07 1995 | ICHOR MEDICAL SYSTEMS, INC | Drug delivery system and method |
6055453, | Aug 01 1997 | OncoSec Medical Incorporated | Apparatus for addressing needle array electrodes for electroporation therapy |
6068650, | Aug 01 1997 | OncoSec Medical Incorporated | Method of Selectively applying needle array configurations |
6085115, | May 22 1997 | Massachusetts Institute of Technology | Biopotential measurement including electroporation of tissue surface |
6090106, | Jan 09 1996 | Gyrus Medical Limited | Electrosurgical instrument |
6102885, | Aug 08 1996 | CURVE MEDICAL, LLC | Device for suction-assisted lipectomy and method of using same |
6106521, | Aug 16 1996 | United States Surgical Corporation | Apparatus for thermal treatment of tissue |
6109270, | Feb 04 1997 | NATIONAL AERONAUTICS AND SPACE ADMINISTRATION, ADMINISTRATOR OF THE | Multimodality instrument for tissue characterization |
6122599, | Feb 13 1998 | JONES JAIN, LLP | Apparatus and method for analyzing particles |
6132419, | May 22 1992 | Genetronics, Inc. | Electroporetic gene and drug therapy |
6159163, | May 07 1998 | Cedars-Sinai Medical Center | System for attenuating pain during bone marrow aspiration and method |
6208893, | Dec 07 1998 | OncoSec Medical Incorporated | Electroporation apparatus with connective electrode template |
6210402, | Nov 22 1995 | Arthrocare Corporation | Methods for electrosurgical dermatological treatment |
6212433, | Jul 28 1998 | Boston Scientific Scimed, Inc | Method for treating tumors near the surface of an organ |
6216034, | Aug 01 1997 | OncoSec Medical Incorporated | Method of programming an array of needle electrodes for electroporation therapy of tissue |
6219577, | Apr 14 1998 | GMP DRUG DELIVERY, INC | Iontophoresis, electroporation and combination catheters for local drug delivery to arteries and other body tissues |
6241702, | Aug 12 1992 | Vidamed, Inc. | Radio frequency ablation device for treatment of the prostate |
6261831, | Mar 26 1999 | The United States of America as represented by the Secretary of the Air; GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE, THE | Ultra-wide band RF-enhanced chemotherapy for cancer treatmeat |
6278895, | Apr 27 1997 | Ichor Medical Systems, Inc. | Electrodes and electrode arrays for generating electroporation inducing electrical fields |
6300108, | Jul 21 1999 | Regents of the University of California, The | Controlled electroporation and mass transfer across cell membranes |
6326177, | Aug 04 1999 | OLD DOMINION UNIVERSITY RESEARCH FOUNDATION | Method and apparatus for intracellular electro-manipulation |
6347247, | May 08 1998 | OncoSec Medical Incorporated | Electrically induced vessel vasodilation |
6349233, | Feb 22 1993 | ELA MEDICAL, S A | Neuro-stimulation to control pain during cardioversion defibrillation |
6351674, | Nov 23 1998 | Synaptic Corporation | Method for inducing electroanesthesia using high frequency, high intensity transcutaneous electrical nerve stimulation |
6387671, | Jul 21 1999 | REGENTS OF THE UNIVERSITY OF CALIFORNIA,THE | Electrical impedance tomography to control electroporation |
6403348, | Jul 21 1999 | Regents of the University of California, The | Controlled electroporation and mass transfer across cell membranes |
6470211, | Jun 03 1997 | UAB Research Foundation | Method and apparatus for treating cardiac arrhythmia |
6482619, | Jul 21 1999 | The Regents of the University of California | Cell/tissue analysis via controlled electroporation |
6493592, | Dec 01 1999 | MEAGAN MEDICAL, INC | Percutaneous electrical therapy system with electrode position maintenance |
6500173, | Jul 18 1996 | Arthrocare Corporation | Methods for electrosurgical spine surgery |
6526320, | Nov 16 1998 | United States Surgical Corporation | Apparatus for thermal treatment of tissue |
6562604, | Jul 21 1999 | The Regents of the University of California | Controlled electroporation and mass transfer across cell membranes |
6607529, | Jun 19 1995 | VIDAMED, INC | Electrosurgical device |
6611706, | Nov 09 1998 | Syneron Medical Ltd | Monopolar and bipolar current application for transdermal drug delivery and analyte extraction |
6613211, | Aug 27 1999 | Monogram Biosciences, Inc | Capillary electrokinesis based cellular assays |
6627421, | Apr 13 1999 | CEREVAST THERAPEUTICS, INC | Methods and systems for applying multi-mode energy to biological samples |
6653091, | Sep 30 1998 | Lifescan IP Holdings, LLC | Method and device for predicting physiological values |
6669691, | Jul 18 2000 | Boston Scientific Scimed, Inc | Epicardial myocardial revascularization and denervation methods and apparatus |
6692493, | Feb 11 1998 | Cosman Company, Inc.; The General Hospital Corporation | Method for performing intraurethral radio-frequency urethral enlargement |
6697669, | Jul 13 1998 | GENETRONICS, INC | Skin and muscle-targeted gene therapy by pulsed electrical field |
6697670, | Aug 17 2001 | AngioDynamics, Inc | Apparatus and method for reducing subcutaneous fat deposits by electroporation with improved comfort of patients |
6702808, | Sep 28 2000 | Syneron Medical Ltd | Device and method for treating skin |
6795728, | Aug 17 2001 | AngioDynamics, Inc | Apparatus and method for reducing subcutaneous fat deposits by electroporation |
6801804, | May 03 2002 | ACIONT, INC | Device and method for monitoring and controlling electrical resistance at a tissue site undergoing iontophoresis |
6865416, | May 08 1998 | OncoSec Medical Incorporated | Electrically induced vessel vasodilation |
6892099, | Feb 08 2001 | AngioDynamics, Inc | Apparatus and method for reducing subcutaneous fat deposits, virtual face lift and body sculpturing by electroporation |
6912417, | Apr 05 2002 | ICHOR MEDICAL SYSTEMS, INC | Method and apparatus for delivery of therapeutic agents |
6927049, | Jul 21 1999 | Regents of the University of California, The | Cell viability detection using electrical measurements |
6962587, | Jul 25 2000 | AngioDynamics, Inc | Method for detecting and treating tumors using localized impedance measurement |
6972014, | Jan 04 2003 | Varian Medical Systems, Inc | Open system heat exchange catheters and methods of use |
6994706, | Aug 13 2001 | AngioDynamics, Inc | Apparatus and method for treatment of benign prostatic hyperplasia |
7053063, | Jul 21 1999 | The Regents of the University of California | Controlled electroporation and mass transfer across cell membranes in tissue |
7063698, | Jun 14 2002 | Atricure, Inc | Vacuum coagulation probes |
7130697, | Aug 13 2002 | AngioDynamics, Inc | Apparatus and method for the treatment of benign prostatic hyperplasia |
7211083, | Mar 17 2003 | AngioDynamics, Inc | Apparatus and method for hair removal by electroporation |
7267676, | Mar 17 2003 | AngioDynamics, Inc | Method for hair removal by electroporation |
20010044596, | |||
20020010491, | |||
20020055731, | |||
20020077676, | |||
20020099323, | |||
20020138117, | |||
20020193831, | |||
20030009110, | |||
20030060856, | |||
20030088189, | |||
20030130711, | |||
20030170898, | |||
20030208200, | |||
20030225360, | |||
20040019371, | |||
20040059389, | |||
20040146877, | |||
20040153057, | |||
20040243107, | |||
20040267189, | |||
20050043726, | |||
20050049541, | |||
20050165393, | |||
20050171523, | |||
20050171574, | |||
20050182462, | |||
20050261672, | |||
20050288730, | |||
20060015147, | |||
20060025760, | |||
20060079883, | |||
20060121610, | |||
20060212078, | |||
20060217703, | |||
20060264752, | |||
20070043345, | |||
20070118069, | |||
20080052786, | |||
DE4000893, | |||
DE863111, | |||
EP378132, | |||
EP935482, | |||
WO20554, | |||
WO107583, | |||
WO107584, | |||
WO107585, | |||
WO181533, | |||
WO4037341, | |||
WO9639531, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Oct 01 2009 | AngioDynamics, Inc. | (assignment on the face of the patent) | / | |||
May 22 2012 | AngioDynamics, Inc | JPMORGAN CHASE BANK, N A , AS ADMINISTRATIVE AGENT | SECURITY AGREEMENT | 028260 | /0329 | |
Sep 19 2013 | AngioDynamics, Inc | JPMORGAN CHASE BANK, N A , AS ADMINISTRATIVE AGENT | SECURITY AGREEMENT | 031315 | /0720 | |
Sep 19 2013 | JPMORGAN CHASE BANK N A , AS ADMINISTRATIVE AGENT | AngioDynamics, Inc | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 031315 | /0361 | |
Nov 07 2016 | AngioDynamics, Inc | JPMORGAN CHASE BANK, N A , AS ADMINISTRATIVE AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 040613 | /0049 | |
Nov 07 2016 | JPMORGAN CHASE BANK, N A , AS ADMINISTRATIVE AGENT | AngioDynamics, Inc | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 040688 | /0540 | |
Jun 03 2019 | AngioDynamics, Inc | JPMORGAN CHASE BANK, N A , AS ADMINISTRATIVE AGENT | CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS | 049371 | /0657 | |
Aug 30 2022 | AngioDynamics, Inc | JPMORGAN CHASE BANK, N A , AS ADMINISTRATIVE AGENT | SECURITY INTEREST SEE DOCUMENT FOR DETAILS | 061360 | /0668 | |
Aug 30 2022 | JPMORGAN CHASE BANK, N A , AS ADMINISTRATIVE AGENT | AngioDynamics, Inc | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 061363 | /0446 | |
Jun 08 2023 | JPMORGAN CHASE BANK, N A , AS ADMINISTRATIVE AGENT | AngioDynamics, Inc | RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS | 063940 | /0362 |
Date | Maintenance Fee Events |
Aug 12 2015 | M1553: Payment of Maintenance Fee, 12th Year, Large Entity. |
Date | Maintenance Schedule |
Oct 11 2014 | 4 years fee payment window open |
Apr 11 2015 | 6 months grace period start (w surcharge) |
Oct 11 2015 | patent expiry (for year 4) |
Oct 11 2017 | 2 years to revive unintentionally abandoned end. (for year 4) |
Oct 11 2018 | 8 years fee payment window open |
Apr 11 2019 | 6 months grace period start (w surcharge) |
Oct 11 2019 | patent expiry (for year 8) |
Oct 11 2021 | 2 years to revive unintentionally abandoned end. (for year 8) |
Oct 11 2022 | 12 years fee payment window open |
Apr 11 2023 | 6 months grace period start (w surcharge) |
Oct 11 2023 | patent expiry (for year 12) |
Oct 11 2025 | 2 years to revive unintentionally abandoned end. (for year 12) |